Range
1.77 - 1.9
Vol / Avg.
600.1K/817.8K
Div / Yield
-
52 Wk
1.03 - 3.35
Mkt Cap
62M
Payout Ratio
-
Open
1.87
P/E
-
EPS
-0.22
Shares
32.6M
Outstanding
32.6M
Total Float
32M
load more
Sector: Health Care.Industry: Biotechnology
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS-0.170-0.230 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
KTRAKintara Therapeutics3.26%62M

Kintara Therapeutics Frequently Asked Questions

Q

How do I buy Kintara Therapeutics (KTRA) stock?

A

You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kintara Therapeutics's (KTRA) competitors?

Q

What is the target price for Kintara Therapeutics (KTRA) stock?

A

The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Aegis Capital on February 3, 2021. The analyst firm set a price target for 7.00 expecting KTRA to rise to within 12 months (a possible 268.42% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kintara Therapeutics (KTRA)?

A

The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $1.9 last updated Thu Jun 17 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Kintara Therapeutics (KTRA) pay a dividend?

A

There are no upcoming dividends for Kintara Therapeutics.

Q

When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?

A
Kintara Therapeutics’s Q3 earnings are confirmed for after-market on May 14, 2021.
Q

Is Kintara Therapeutics (KTRA) going to split?

A

There is no upcoming split for Kintara Therapeutics.

Q

What sector and industry does Kintara Therapeutics (KTRA) operate in?

A

Kintara Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.